Taiko Pharmaceutical Co., Ltd. (4574)
Market Open
2 Oct, 06:00 AM
JPX JPX Primary ¥
252. 00
-4
-1.5625%
¥
15.16B Market Cap
- P/E Ratio
13.2% Div Yield
98,400 Volume
- Eps
¥ 256
Previous Close Want to track 4574 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taiko Pharmaceutical Co., Ltd. (4574) Statistics
Valuation metrics
Market Cap 15.16B
Enterprise value 10.79B
Trailing P/E (ttm) 19.28
Forward P/E 55.43
PEG ratio 0.29
Price/Sales (ttm) 2.01
Price/Book (mrq) 1.57
Enterprise Value/Revenue 1.63
Enterprise Value/EBITDA 12.23
Overview
Shares outstanding 50.25M
Float 23.83M
Shares short -
% Held by insiders 0.37%
% Held by institutions 0.06%
Average volume (10 days) 101.2K
Average volume (90 days) 124.49K
Price summary
52-Week low 246
52-Week high 317
Beta 0.05
50-Day moving average 255.96
200-Day moving average 269.06
Dividends and splits
Forward annual dividend rate 13.2
Forward annual dividend yield 0.0514%
Trailing annual dividend rate 3.3
Trailing annual dividend yield 0.0125%
5-Year annual dividend yield 1.04%
Payout ratio 0.18
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 30 Mar 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin 0.1%
Operating margin 0.06%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.08%
Income Statement
Revenue (ttm) 22.46B
Revenue per share (ttm) 131.74
Quarterly revenue growth (yoy) 0.16%
Gross profit (ttm) 15.54B
EBITDA 881M
Net income to common (ttm) 4.18B
Diluted EPS (ttm) 13.69
Quarterly earnings growth (yoy) -0.33%
Balance Sheet
Total cash (mrq) 4.94B
Total cash per share (mrq) 62.99
Total debt (mrq) 94M
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 5.13%
Book value per share (mrq) 167.67
Cash Flow
Cash flow statement 1.03B
Levered free cash flow (LFCF) 923M
2026 © Marketlog. All Rights Reserved.
